DEEGtal

Country:
Switzerland
Founding year:
2024

dEEGtal develops AI-powered platforms designed to enhance the analysis of electroencephalography (EEG) data for neurological diagnosis. The company’s technology focuses on uncovering complex, visually silent patterns in EEG recordings that may be missed by conventional review. Its approach emphasizes faster, more accurate detection of abnormalities to support epilepsy diagnosis and monitoring. dEEGtal positions its platform within clinical neurodiagnostic and research contexts.

The technology applies machine learning algorithms to raw EEG signals, identifying subtle temporal and spatial patterns associated with epileptiform activity. By highlighting these patterns, the system enables clinicians to detect seizures or predisposing neural events more efficiently. Automated analysis reduces reliance on manual review while maintaining interpretability and clinical relevance. The platform emphasizes reproducibility, speed, and integration with existing EEG workflows.

dEEGtal targets clinicians, hospitals, and research institutions involved in epilepsy diagnosis and management. The platform is intended to complement expert review and improve diagnostic accuracy rather than replace clinical judgment. Its positioning reflects growing interest in AI-driven EEG analytics to enhance neurological assessment and streamline care for epilepsy patients.

Neuroimaging
Biomarkers
Diagnostics

Articles about

DEEGtal

No articles yet!